Clinical Trial Costs Hit $41M as Drug Makers Turn to Data Platforms

Pharmaceutical companies face mounting pressure to accelerate drug development while managing pivotal trials that now average $41 million each. H1, a healthcare professional data analytics platform, has closed a $40 million funding round led by CVS Health Ventures to address this squeeze. The platform identifies and engages clinical investigators and trial sites more efficiently, directly tackling the cost and timeline constraints reshaping how new drugs reach patients.